摘要
目的:探讨SPECT/CT融合显像在原发性甲状旁腺功能亢进症(PHPT)术前诊断中的应用价值。方法:回顾性分析2017年2月~2019年1月就诊于本院的52例PHPT患者临床资料,术前30d均接受99TCm-MIBI SPECT/CT融合显像检查。以病理诊断为金标准,分析99TCm-MIBI SPECT/CT融合显像检查PHPT的检出率和不同病灶的检出率。结果:52例患者经病理诊断共73处病灶,其中异位甲状旁腺腺瘤3例(3处病灶),甲状旁腺腺瘤42例(55处病灶),甲状旁腺增生3例(12处病灶),甲状旁腺癌术后淋巴结转移3例(3处病灶);经99TCm-MIBI SPECT/CT融合显像检查确诊患者52例,检出病灶63个,检出率为86.30%(63/73),其中异位甲状旁腺腺瘤3处(100.00%),甲状旁腺腺瘤52处(94.55%),甲状旁腺增生5处(41.67%),甲状旁腺癌术后淋巴结转移3处(100.00%)。结论:99TCm-MIBI SPECT/CT融合显像是检测PHPT的有效方式,可精确定位病灶,为手术提供重要参考依据。
Objective:To explore the application value of SPECT/CT fusion imaging in preoperative diagnosis of primary hyperparathyroidism(PHPT).Methods:Retrospectively analyzed the clinical data of 52 patients with PHPT who visited our hospital from February 2017 to January 2019.All patients received 99TCm-MIBI SPECT/CT fusion imaging 30 days before surgery.Using pathological diagnosis as the gold standard,the detection rate of PHPT and the detection rate of different lesions were analyzed by 99TCm-MIBI SPECT/CT fusion imaging.Results:A total of 73 lesions were diagnosed by pathology in 52 patients,including 3 cases of ectopic parathyroid adenoma(3 lesions),42 cases of parathyroid adenoma(55 lesions),and 3 cases of parathyroid hyperplasia(12 Lesions),3 cases of lymph node metastasis after parathyroid carcinoma surgery(3 lesions);52 patients were diagnosed by 99TCm-MIBI SPECT/CT fusion imaging,63 lesions were detected,and the detection rate was 86.30%(63/73),including 3 ectopic parathyroid adenoma(100.00%),52 parathyroid adenoma(94.55%),5 parathyroid hyperplasia(41.67%),lymph node metastasis after parathyroid carcinoma surgery 3 locations(100.00%).Conclusion:99TCm-MIBI SPECT/CT fusion imaging is an effective way to detect PHPT,which can accurately locate the lesion and provide an important reference for surgery.
作者
王毅
WANG Yi(Department of Radiology,Tianjin Wuqing District People’s Hospital,Tianjin 301700)
出处
《中国医疗器械信息》
2020年第8期155-156,共2页
China Medical Device Information
